We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PepsiCo Inc. (PEP - Free Report) has successfully completed the buyout of the CytoSport business from Hormel Foods Corporation (HRL - Free Report) to overcome the effects of the fall in carbonated soft drinks ('CSD') category sales. The company paid about $465 million for CytoSport, which comprises of Muscle Milk and Evolve brands.
The Muscle Milk brand should fully complement PepsiCo’s existing brands in the sports nutrition category. Further, PepsiCo’s long-standing distribution deal with CytoSport gives it an edge to own and expand this business.
Notably, the CytoSport business is the latest in PepsiCo's acquisitions under the ‘Performance with Purpose’ vision, which encourages health and wellness through cost-effective and environment-friendly beverages.
PepsiCo's shares reacted a little to the buyout news. But it has gained 13.2% in the past three months compared with the industry’s growth of 3.6%. Currently, this beverage and snacking giant carries a Zacks Rank #4 (Sell).
PepsiCo is growing nutrition brands — including Quaker, Tropicana and Gatorade — to counter headwinds arising from soft CSD sales. Further, it is expanding the portfolio of nutritious products in categories such as dairy, hummus and other fresh dips, and baked grain snacks. The company is also focused on broadening the beverage portfolio to include more non-carbonated beverages to decrease the dependence on colas. PepsiCo has been expanding its value share in a number of fastest-growing categories — including tea, enhanced water and sparkling water. For this, it primarily depends on either innovation or acquisition of new brands.
As part of these efforts, the company acquired Health Warrior Inc. in October 2018. Health Warrior makes plant-based products — including nutrition bars and on-trend offerings. This acquisition expands PepsiCo’s nutrition portfolio, offering additional options to consumers in the nutrition bar category, which is a growing space.
Additionally, the company bought all outstanding shares of SodaStream International Ltd. for a cash outlay of $3.2 billion ($144 per share) in December 2018. The acquisition not only fortified PepsiCo’s beverage and fast-growing water portfolio — including Aquafina, Lifewtr and more — but also expanded at-home refreshment beverage offerings. Further, SodaStream expedites PepsiCo’s highly-nutritious and great-tasting beverage offerings.
Looking for Better-Ranked Beverage Stocks? Check These
Ambev S.A. (ABEV - Free Report) , also a Zacks Rank #2 company, has average long-term EPS growth rate of 7.2%.
Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Image: Bigstock
PepsiCo Closes CytoSport Buyout, Fortifies Nutrition Portfolio
PepsiCo Inc. (PEP - Free Report) has successfully completed the buyout of the CytoSport business from Hormel Foods Corporation (HRL - Free Report) to overcome the effects of the fall in carbonated soft drinks ('CSD') category sales. The company paid about $465 million for CytoSport, which comprises of Muscle Milk and Evolve brands.
The Muscle Milk brand should fully complement PepsiCo’s existing brands in the sports nutrition category. Further, PepsiCo’s long-standing distribution deal with CytoSport gives it an edge to own and expand this business.
Notably, the CytoSport business is the latest in PepsiCo's acquisitions under the ‘Performance with Purpose’ vision, which encourages health and wellness through cost-effective and environment-friendly beverages.
PepsiCo's shares reacted a little to the buyout news. But it has gained 13.2% in the past three months compared with the industry’s growth of 3.6%. Currently, this beverage and snacking giant carries a Zacks Rank #4 (Sell).
PepsiCo is growing nutrition brands — including Quaker, Tropicana and Gatorade — to counter headwinds arising from soft CSD sales. Further, it is expanding the portfolio of nutritious products in categories such as dairy, hummus and other fresh dips, and baked grain snacks. The company is also focused on broadening the beverage portfolio to include more non-carbonated beverages to decrease the dependence on colas. PepsiCo has been expanding its value share in a number of fastest-growing categories — including tea, enhanced water and sparkling water. For this, it primarily depends on either innovation or acquisition of new brands.
As part of these efforts, the company acquired Health Warrior Inc. in October 2018. Health Warrior makes plant-based products — including nutrition bars and on-trend offerings. This acquisition expands PepsiCo’s nutrition portfolio, offering additional options to consumers in the nutrition bar category, which is a growing space.
Additionally, the company bought all outstanding shares of SodaStream International Ltd. for a cash outlay of $3.2 billion ($144 per share) in December 2018. The acquisition not only fortified PepsiCo’s beverage and fast-growing water portfolio — including Aquafina, Lifewtr and more — but also expanded at-home refreshment beverage offerings. Further, SodaStream expedites PepsiCo’s highly-nutritious and great-tasting beverage offerings.
Looking for Better-Ranked Beverage Stocks? Check These
New Age Beverage Corporation’s estimates for the current fiscal year witnessed positive revisions in the last 30 days. The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Ambev S.A. (ABEV - Free Report) , also a Zacks Rank #2 company, has average long-term EPS growth rate of 7.2%.
Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Click to get it free >>